• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发肿瘤无明确切除意图手术治疗小肠和右半结直肠转移性神经内分泌肿瘤的效果:荟萃分析。

Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis.

机构信息

Department of Surgery, Skåne University Hospital, Lund, Sweden.

Department of Clinical Sciences, Lund University, Lund, Sweden.

出版信息

Br J Surg. 2022 Feb 1;109(2):191-199. doi: 10.1093/bjs/znab413.

DOI:10.1093/bjs/znab413
PMID:34941998
Abstract

BACKGROUND

Patients with small intestinal neuroendocrine tumours (siNETs) usually present with advanced disease. Primary tumour resection without curative intent is controversial in patients with metastatic siNETs. The aim of this meta-analysis was to investigate survival after primary tumour resection without curative intent compared with no resection in patients with metastatic siNETs.

METHODS

A systematic literature search was performed, using MEDLINE® (PubMed), Embase®, Web of Science, and the Cochrane Library up to 25 February 2021. Studies were included if survival after primary tumour resection versus no resection in patients with metastatic siNETs was reported. Results were pooled in a random-effects meta-analysis, and are reported as hazard ratios (HRs) with 95 per cent confidence intervals. Sensitivity analyses were undertaken to enable comment on the impact of important confounders.

RESULTS

After screening 3659 abstracts, 16 studies, published between 1992 and 2021, met the inclusion criteria, with a total of 9428 patients. Thirteen studies reported HRs adjusted for important confounders and were included in the meta-analysis. Median overall survival was 112 (i.q.r. 82-134) months in the primary tumour resection group compared with 60 (74-88) months in the group without resection. Five-year overall survival rates were 74 (i.q.r. 67-77) and 44 (34-45) per cent respectively. Primary tumour resection was associated with improved survival compared with no resection (HR 0.55, 95 per cent c.i. 0.47 to 0.66). This effect remained in sensitivity analyses.

CONCLUSION

Primary tumour resection is associated with increased survival in patients with advanced, metastatic siNETs, even after adjusting for important confounders.

摘要

背景

患有小肠类癌肿瘤(siNETs)的患者通常患有晚期疾病。对于转移性 siNETs 患者,无治愈意图的原发肿瘤切除术存在争议。本荟萃分析的目的是研究与无切除术相比,无治愈意图的原发肿瘤切除术对转移性 siNETs 患者的生存影响。

方法

使用 MEDLINE®(PubMed)、Embase®、Web of Science 和 Cochrane 图书馆进行系统文献检索,检索时间截至 2021 年 2 月 25 日。如果报道了转移性 siNETs 患者的原发肿瘤切除术与无切除术之间的生存情况,则纳入研究。使用随机效应荟萃分析汇总结果,并以 95%置信区间的风险比(HR)报告。进行敏感性分析,以评论重要混杂因素的影响。

结果

在筛选了 3659 篇摘要后,16 项研究符合纳入标准,发表时间为 1992 年至 2021 年,共纳入 9428 例患者。其中 13 项研究报告了经重要混杂因素调整的 HR,并纳入荟萃分析。原发肿瘤切除术组的中位总生存期为 112(IQR 82-134)个月,无切除术组为 60(74-88)个月。5 年总生存率分别为 74(IQR 67-77)%和 44(34-45)%。与无切除术相比,原发肿瘤切除术与生存改善相关(HR 0.55,95%CI 0.47-0.66)。该效应在敏感性分析中仍然存在。

结论

即使在调整了重要混杂因素后,对于患有晚期转移性 siNETs 的患者,原发肿瘤切除术与生存增加相关。

相似文献

1
Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis.原发肿瘤无明确切除意图手术治疗小肠和右半结直肠转移性神经内分泌肿瘤的效果:荟萃分析。
Br J Surg. 2022 Feb 1;109(2):191-199. doi: 10.1093/bjs/znab413.
2
Long-term survival of metastatic small intestine neuroendocrine tumors: a meta-analysis.转移性小肠神经内分泌肿瘤的长期生存:一项荟萃分析
Endocr Relat Cancer. 2022 Feb 7;29(3):163-173. doi: 10.1530/ERC-21-0354.
3
Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: A systematic review and meta-analysis.原发性肿瘤姑息性切除在晚期胰腺和小肠神经内分泌肿瘤中的作用:一项系统评价和荟萃分析
Eur J Surg Oncol. 2017 Oct;43(10):1808-1815. doi: 10.1016/j.ejso.2017.05.016. Epub 2017 May 25.
4
Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study.小肠神经内分泌肿瘤的生存结局与手术干预:一项基于人群的回顾性研究
Oncotarget. 2017 Jan 17;8(3):4935-4947. doi: 10.18632/oncotarget.13632.
5
Postoperative morbidity and mortality after surgical resection of small bowel neuroendocrine neoplasms: A systematic review and meta-analysis.小肠神经内分泌肿瘤切除术后的发病率和死亡率:系统评价和荟萃分析。
J Neuroendocrinol. 2021 Aug;33(8):e13008. doi: 10.1111/jne.13008. Epub 2021 Jul 8.
6
Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis.原发于中肠的神经内分泌肿瘤患者伴无法切除的肝转移时,是否有必要行原发肿瘤切除术?一项系统回顾和荟萃分析。
J Gastrointest Surg. 2019 May;23(5):1044-1054. doi: 10.1007/s11605-018-04094-9. Epub 2019 Jan 22.
7
Prognostic factors influencing survival in small bowel neuroendocrine tumor with liver metastases.影响伴有肝转移的小肠类癌肿瘤患者生存预后的因素分析。
J Surg Oncol. 2019 Nov;120(6):926-931. doi: 10.1002/jso.25657. Epub 2019 Aug 8.
8
Prognostic Factors Associated with Outcomes in Small Bowel Neuroendocrine Tumors.小肠神经内分泌肿瘤预后相关因素与结局的关系
Am Surg. 2017 Oct 1;83(10):1174-1178.
9
Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.原发肿瘤切除术可能延长转移性胃肠胰神经内分泌肿瘤患者的生存时间。
Surgery. 2019 Mar;165(3):644-651. doi: 10.1016/j.surg.2018.09.006. Epub 2018 Oct 23.
10
Palliative resection of primary site in advanced gastroenteropancreatic neuroendocrine tumors improves survivals.晚期胃肠胰神经内分泌肿瘤原发部位的姑息性切除可提高生存率。
Turk J Gastroenterol. 2019 Oct;30(10):910-916. doi: 10.5152/tjg.2019.19168.

引用本文的文献

1
Primary tumor resection might improve outcomes in metastatic thoracic esophageal cancer.原发性肿瘤切除可能改善转移性胸段食管癌的预后。
Sci Rep. 2025 Jan 24;15(1):3054. doi: 10.1038/s41598-025-85419-y.
2
Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease.615例小肠神经内分泌肿瘤患者的预后:手术后的复发风险及晚期疾病的疾病特异性生存率
Cancers (Basel). 2024 Jan 1;16(1):204. doi: 10.3390/cancers16010204.
3
Management of Small Bowel Neuroendocrine Tumours: 10 Years' Experience at a Tertiary Referral Centre.
小肠神经内分泌肿瘤的管理:三级转诊中心的十年经验
Cancers (Basel). 2023 Sep 6;15(18):4438. doi: 10.3390/cancers15184438.
4
Small Bowel Neuroendocrine Tumors-10-Year Experience of the Ottawa Hospital (TOH).小肠神经内分泌肿瘤-渥太华医院(TOH) 10 年经验。
Curr Oncol. 2023 Aug 9;30(8):7508-7519. doi: 10.3390/curroncol30080544.
5
Surgical Approach to Liver Metastases in GEP-NET in a Tertiary Reference Center.三级转诊中心中GEP-NET肝转移的手术治疗方法
Cancers (Basel). 2023 Mar 29;15(7):2048. doi: 10.3390/cancers15072048.
6
Molecular factors, diagnosis and management of gastrointestinal tract neuroendocrine tumors: An update.胃肠道神经内分泌肿瘤的分子因素、诊断与管理:最新进展
World J Clin Cases. 2022 Sep 26;10(27):9573-9587. doi: 10.12998/wjcc.v10.i27.9573.